US Stock MarketDetailed Quotes

BMY Bristol-Myers Squibb

Watchlist
  • 53.900
  • -2.070-3.70%
Close Feb 14 16:00 ET
  • 53.790
  • -0.110-0.20%
Post 20:01 ET
109.38BMarket Cap-12.22P/E (TTM)

Bristol-Myers Squibb Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
-11.57%10.86B
-11.57%10.86B
5.32%8.09B
-23.79%6.65B
4.33%9.67B
32.71%12.28B
32.71%12.28B
-14.87%7.69B
-34.19%8.73B
-39.00%9.27B
-Cash and cash equivalents
-9.75%10.35B
-9.75%10.35B
5.00%7.89B
-24.83%6.29B
3.72%9.33B
25.66%11.46B
25.66%11.46B
-2.84%7.51B
-22.12%8.37B
-27.28%9B
-Short-term investments
-37.13%513M
-37.13%513M
19.30%204M
0.56%360M
24.09%340M
527.69%816M
527.69%816M
-86.77%171M
-85.77%358M
-90.31%274M
Receivables
-5.50%14.42B
-5.50%14.42B
-4.81%14.9B
0.58%15.15B
4.89%14.06B
9.52%15.26B
9.52%15.26B
18.18%15.65B
20.09%15.06B
20.73%13.41B
-Accounts receivable
1.46%9.01B
1.46%9.01B
10.82%9.32B
19.95%9.75B
12.38%8.83B
8.97%8.88B
8.97%8.88B
4.81%8.41B
7.11%8.13B
9.75%7.85B
-Taxes receivable
-16.17%3.29B
-16.17%3.29B
-29.54%3.48B
-26.53%3.34B
12.61%3.21B
10.71%3.93B
10.71%3.93B
55.08%4.93B
48.09%4.54B
30.43%2.85B
-Other receivables
-13.65%2.12B
-13.65%2.12B
-8.89%2.1B
-13.75%2.06B
-24.99%2.03B
9.65%2.46B
9.65%2.46B
13.20%2.31B
26.76%2.39B
53.26%2.71B
Inventory
-3.94%2.56B
-3.94%2.56B
36.78%3.33B
30.16%3.08B
14.59%2.99B
13.81%2.66B
13.81%2.66B
17.45%2.44B
10.36%2.36B
23.81%2.61B
Restricted cash
--0
--0
-96.30%2M
-96.23%2M
-96.23%2M
-62.84%55M
-62.84%55M
-67.07%54M
-65.36%53M
-65.81%53M
Other current assets
28.56%1.94B
28.56%1.94B
-3.20%1.75B
7.71%2.01B
11.29%1.95B
-5.45%1.51B
-5.45%1.51B
-21.00%1.81B
-10.41%1.87B
12.22%1.75B
Total current assets
-6.26%29.78B
-6.26%29.78B
1.60%28.08B
-4.22%26.89B
5.84%28.67B
16.49%31.77B
16.49%31.77B
3.12%27.63B
-7.00%28.07B
-10.08%27.09B
Non current assets
Net PPE
4.03%8.36B
4.03%8.36B
5.14%8.25B
6.97%8.16B
7.64%8.19B
7.51%8.04B
7.51%8.04B
13.44%7.85B
12.03%7.63B
9.57%7.61B
-Gross PPE
3.66%13.31B
3.66%13.31B
4.70%13.09B
9.43%13.25B
10.82%13.13B
10.31%12.84B
10.31%12.84B
13.04%12.5B
11.73%12.11B
6.64%11.85B
-Accumulated depreciation
-3.04%-4.95B
-3.04%-4.95B
-3.98%-4.84B
-13.63%-5.09B
-16.53%-4.94B
-15.35%-4.8B
-15.35%-4.8B
-12.37%-4.65B
-11.23%-4.48B
-1.78%-4.24B
Goodwill and other intangible assets
-6.77%45.36B
-6.77%45.36B
-2.86%49.08B
-2.58%51.57B
-0.56%54.91B
-15.39%48.65B
-15.39%48.65B
-15.57%50.52B
-9.83%52.94B
-9.37%55.22B
-Goodwill
2.60%21.72B
2.60%21.72B
2.86%21.75B
2.69%21.73B
2.72%21.74B
0.09%21.17B
0.09%21.17B
0.17%21.15B
3.51%21.16B
3.23%21.16B
-Other intangible assets
-13.98%23.64B
-13.98%23.64B
-6.98%27.33B
-6.09%29.84B
-2.60%33.17B
-24.40%27.49B
-24.40%27.49B
-24.14%29.38B
-16.96%31.77B
-15.75%34.05B
Investments and advances
0.36%2.51B
0.36%2.51B
23.29%2.85B
50.63%3B
43.89%2.89B
14.27%2.5B
14.27%2.5B
18.12%2.31B
0.91%1.99B
-8.24%2.01B
Non current deferred assets
53.03%4.24B
53.03%4.24B
138.38%3.61B
111.39%3.32B
106.76%2.72B
105.95%2.77B
105.95%2.77B
13.92%1.51B
17.58%1.57B
-7.12%1.32B
Defined pension benefit
-17.61%234M
-17.61%234M
-23.99%225M
-29.53%210M
-3.01%290M
-0.35%284M
-0.35%284M
-1.66%296M
-5.40%298M
-6.85%299M
Other non current assets
84.93%2.12B
84.93%2.12B
39.12%1.58B
50.86%1.49B
82.34%1.37B
52.66%1.15B
52.66%1.15B
7.58%1.14B
-3.79%989M
-33.13%753M
Total non current assets
-0.89%62.82B
-0.89%62.82B
3.09%65.6B
3.58%67.76B
4.71%70.36B
-8.85%63.39B
-8.85%63.39B
-10.88%63.63B
-6.78%65.42B
-7.84%67.2B
Total assets
-2.69%92.6B
-2.69%92.6B
2.64%93.67B
1.24%94.65B
5.04%99.03B
-1.72%95.16B
-1.72%95.16B
-7.06%91.26B
-6.84%93.49B
-8.50%94.28B
Liabilities
Current liabilities
Payables
9.09%6.37B
9.09%6.37B
13.70%6.18B
11.34%6.44B
11.46%6.24B
12.84%5.84B
12.84%5.84B
7.97%5.43B
11.76%5.79B
11.44%5.6B
-accounts payable
10.52%3.6B
10.52%3.6B
23.32%3.47B
22.22%3.75B
10.80%3.54B
7.20%3.26B
7.20%3.26B
8.40%2.81B
6.49%3.07B
8.49%3.19B
-Total tax payable
10.43%1.51B
10.43%1.51B
2.13%1.49B
-3.41%1.47B
22.99%1.49B
45.54%1.37B
45.54%1.37B
13.29%1.46B
33.74%1.53B
30.00%1.21B
-Dividends payable
3.71%1.26B
3.71%1.26B
4.91%1.22B
2.18%1.22B
1.59%1.22B
1.42%1.21B
1.42%1.21B
1.05%1.16B
3.21%1.19B
4.00%1.2B
Current accrued expenses
63.90%572M
63.90%572M
38.01%512M
94.41%591M
71.16%546M
8.72%349M
8.72%349M
19.29%371M
-13.64%304M
-10.39%319M
Current debt and capital lease obligation
-32.12%2.23B
-32.12%2.23B
-77.87%1.24B
16.31%3.71B
117.55%6.36B
-25.43%3.28B
-25.43%3.28B
144.32%5.62B
-37.73%3.19B
-62.00%2.92B
-Current debt
-34.40%2.05B
-34.40%2.05B
-80.28%1.08B
16.92%3.53B
124.93%6.19B
-26.85%3.12B
-26.85%3.12B
156.43%5.47B
-39.03%3.02B
-63.41%2.75B
-Current capital lease obligation
11.73%181M
11.73%181M
10.00%165M
5.36%177M
-1.17%169M
19.12%162M
19.12%162M
-10.18%150M
0.60%168M
0.00%171M
Other current liabilities
12.25%12.91B
12.25%12.91B
20.27%13.43B
14.86%11.6B
24.96%12.06B
8.82%11.5B
8.82%11.5B
8.61%11.17B
6.68%10.1B
6.26%9.65B
Current liabilities
6.79%23.77B
6.79%23.77B
-3.51%22.64B
15.46%23.27B
35.30%25.82B
1.70%22.26B
1.70%22.26B
23.94%23.46B
-3.66%20.15B
-16.37%19.09B
Non current liabilities
Long term debt and capital lease obligation
28.26%48.97B
28.26%48.97B
49.05%50.16B
39.72%50.3B
40.06%51.05B
5.14%38.18B
5.14%38.18B
-11.00%33.65B
-5.07%36B
-4.84%36.45B
-Long term debt
29.87%47.6B
29.87%47.6B
51.46%48.67B
40.98%48.86B
41.08%49.49B
4.56%36.65B
4.56%36.65B
-13.06%32.14B
-6.61%34.66B
-6.33%35.08B
-Long term capital lease obligation
-10.46%1.37B
-10.46%1.37B
-1.98%1.48B
7.15%1.44B
14.09%1.56B
21.33%1.53B
21.33%1.53B
79.05%1.51B
64.66%1.34B
60.80%1.37B
Non current deferred liabilities
-0.94%1.06B
-0.94%1.06B
5.00%1.15B
-18.09%1.19B
-47.33%1.19B
-61.94%1.07B
-61.94%1.07B
-68.73%1.1B
-60.65%1.45B
-50.12%2.26B
Employee benefits
-16.67%400M
-16.67%400M
15.80%447M
17.09%466M
19.55%477M
19.40%480M
19.40%480M
-30.20%386M
-32.43%398M
-36.16%399M
Other non current liabilities
31.82%522M
31.82%522M
36.50%531M
96.59%576M
98.63%582M
30.69%396M
30.69%396M
51.95%389M
40.19%293M
36.28%293M
Total non current liabilities
20.80%52.44B
20.80%52.44B
38.96%53.83B
31.48%54.31B
30.83%56.66B
-0.91%43.41B
-0.91%43.41B
-16.75%38.74B
-11.70%41.31B
-10.83%43.31B
Total liabilities
16.05%76.22B
16.05%76.22B
22.94%76.47B
26.23%77.58B
32.19%82.48B
-0.04%65.67B
-0.04%65.67B
-4.98%62.2B
-9.21%61.46B
-12.60%62.4B
Shareholders'equity
Share capital
0.00%292M
0.00%292M
0.00%292M
0.00%292M
0.00%292M
0.00%292M
0.00%292M
0.00%292M
0.00%292M
0.00%292M
-common stock
0.00%292M
0.00%292M
0.00%292M
0.00%292M
0.00%292M
0.00%292M
0.00%292M
0.00%292M
0.00%292M
0.00%292M
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-48.16%14.91B
-48.16%14.91B
-42.95%16.1B
-41.33%16.1B
-41.13%15.64B
12.79%28.77B
12.79%28.77B
14.36%28.22B
13.35%27.45B
10.94%26.57B
Paid-in capital
0.74%46.02B
0.74%46.02B
2.33%45.9B
1.03%45.77B
1.14%45.66B
1.15%45.68B
1.15%45.68B
-0.24%44.85B
2.08%45.3B
3.16%45.14B
Less: Treasury stock
-0.25%43.66B
-0.25%43.66B
1.39%43.68B
10.11%43.69B
12.60%43.7B
13.33%43.77B
13.33%43.77B
18.30%43.08B
12.43%39.68B
10.29%38.81B
Gains losses not affecting retained earnings
19.92%-1.24B
19.92%-1.24B
-14.15%-1.47B
-4.97%-1.46B
-2.34%-1.4B
-20.69%-1.55B
-20.69%-1.55B
-52.91%-1.29B
-39.82%-1.39B
-11.31%-1.37B
Total stockholders'equity
-44.50%16.34B
-44.50%16.34B
-40.89%17.14B
-46.78%17.02B
-48.18%16.49B
-5.25%29.43B
-5.25%29.43B
-11.24%29B
-1.92%31.97B
0.77%31.82B
Noncontrolling interests
-3.64%53M
-3.64%53M
-9.38%58M
-5.26%54M
-6.45%58M
-3.51%55M
-3.51%55M
1.59%64M
-6.56%57M
-4.62%62M
Total equity
-44.42%16.39B
-44.42%16.39B
-40.82%17.2B
-46.71%17.07B
-48.10%16.55B
-5.25%29.49B
-5.25%29.49B
-11.22%29.06B
-1.93%32.03B
0.76%31.89B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments -11.57%10.86B-11.57%10.86B5.32%8.09B-23.79%6.65B4.33%9.67B32.71%12.28B32.71%12.28B-14.87%7.69B-34.19%8.73B-39.00%9.27B
-Cash and cash equivalents -9.75%10.35B-9.75%10.35B5.00%7.89B-24.83%6.29B3.72%9.33B25.66%11.46B25.66%11.46B-2.84%7.51B-22.12%8.37B-27.28%9B
-Short-term investments -37.13%513M-37.13%513M19.30%204M0.56%360M24.09%340M527.69%816M527.69%816M-86.77%171M-85.77%358M-90.31%274M
Receivables -5.50%14.42B-5.50%14.42B-4.81%14.9B0.58%15.15B4.89%14.06B9.52%15.26B9.52%15.26B18.18%15.65B20.09%15.06B20.73%13.41B
-Accounts receivable 1.46%9.01B1.46%9.01B10.82%9.32B19.95%9.75B12.38%8.83B8.97%8.88B8.97%8.88B4.81%8.41B7.11%8.13B9.75%7.85B
-Taxes receivable -16.17%3.29B-16.17%3.29B-29.54%3.48B-26.53%3.34B12.61%3.21B10.71%3.93B10.71%3.93B55.08%4.93B48.09%4.54B30.43%2.85B
-Other receivables -13.65%2.12B-13.65%2.12B-8.89%2.1B-13.75%2.06B-24.99%2.03B9.65%2.46B9.65%2.46B13.20%2.31B26.76%2.39B53.26%2.71B
Inventory -3.94%2.56B-3.94%2.56B36.78%3.33B30.16%3.08B14.59%2.99B13.81%2.66B13.81%2.66B17.45%2.44B10.36%2.36B23.81%2.61B
Restricted cash --0--0-96.30%2M-96.23%2M-96.23%2M-62.84%55M-62.84%55M-67.07%54M-65.36%53M-65.81%53M
Other current assets 28.56%1.94B28.56%1.94B-3.20%1.75B7.71%2.01B11.29%1.95B-5.45%1.51B-5.45%1.51B-21.00%1.81B-10.41%1.87B12.22%1.75B
Total current assets -6.26%29.78B-6.26%29.78B1.60%28.08B-4.22%26.89B5.84%28.67B16.49%31.77B16.49%31.77B3.12%27.63B-7.00%28.07B-10.08%27.09B
Non current assets
Net PPE 4.03%8.36B4.03%8.36B5.14%8.25B6.97%8.16B7.64%8.19B7.51%8.04B7.51%8.04B13.44%7.85B12.03%7.63B9.57%7.61B
-Gross PPE 3.66%13.31B3.66%13.31B4.70%13.09B9.43%13.25B10.82%13.13B10.31%12.84B10.31%12.84B13.04%12.5B11.73%12.11B6.64%11.85B
-Accumulated depreciation -3.04%-4.95B-3.04%-4.95B-3.98%-4.84B-13.63%-5.09B-16.53%-4.94B-15.35%-4.8B-15.35%-4.8B-12.37%-4.65B-11.23%-4.48B-1.78%-4.24B
Goodwill and other intangible assets -6.77%45.36B-6.77%45.36B-2.86%49.08B-2.58%51.57B-0.56%54.91B-15.39%48.65B-15.39%48.65B-15.57%50.52B-9.83%52.94B-9.37%55.22B
-Goodwill 2.60%21.72B2.60%21.72B2.86%21.75B2.69%21.73B2.72%21.74B0.09%21.17B0.09%21.17B0.17%21.15B3.51%21.16B3.23%21.16B
-Other intangible assets -13.98%23.64B-13.98%23.64B-6.98%27.33B-6.09%29.84B-2.60%33.17B-24.40%27.49B-24.40%27.49B-24.14%29.38B-16.96%31.77B-15.75%34.05B
Investments and advances 0.36%2.51B0.36%2.51B23.29%2.85B50.63%3B43.89%2.89B14.27%2.5B14.27%2.5B18.12%2.31B0.91%1.99B-8.24%2.01B
Non current deferred assets 53.03%4.24B53.03%4.24B138.38%3.61B111.39%3.32B106.76%2.72B105.95%2.77B105.95%2.77B13.92%1.51B17.58%1.57B-7.12%1.32B
Defined pension benefit -17.61%234M-17.61%234M-23.99%225M-29.53%210M-3.01%290M-0.35%284M-0.35%284M-1.66%296M-5.40%298M-6.85%299M
Other non current assets 84.93%2.12B84.93%2.12B39.12%1.58B50.86%1.49B82.34%1.37B52.66%1.15B52.66%1.15B7.58%1.14B-3.79%989M-33.13%753M
Total non current assets -0.89%62.82B-0.89%62.82B3.09%65.6B3.58%67.76B4.71%70.36B-8.85%63.39B-8.85%63.39B-10.88%63.63B-6.78%65.42B-7.84%67.2B
Total assets -2.69%92.6B-2.69%92.6B2.64%93.67B1.24%94.65B5.04%99.03B-1.72%95.16B-1.72%95.16B-7.06%91.26B-6.84%93.49B-8.50%94.28B
Liabilities
Current liabilities
Payables 9.09%6.37B9.09%6.37B13.70%6.18B11.34%6.44B11.46%6.24B12.84%5.84B12.84%5.84B7.97%5.43B11.76%5.79B11.44%5.6B
-accounts payable 10.52%3.6B10.52%3.6B23.32%3.47B22.22%3.75B10.80%3.54B7.20%3.26B7.20%3.26B8.40%2.81B6.49%3.07B8.49%3.19B
-Total tax payable 10.43%1.51B10.43%1.51B2.13%1.49B-3.41%1.47B22.99%1.49B45.54%1.37B45.54%1.37B13.29%1.46B33.74%1.53B30.00%1.21B
-Dividends payable 3.71%1.26B3.71%1.26B4.91%1.22B2.18%1.22B1.59%1.22B1.42%1.21B1.42%1.21B1.05%1.16B3.21%1.19B4.00%1.2B
Current accrued expenses 63.90%572M63.90%572M38.01%512M94.41%591M71.16%546M8.72%349M8.72%349M19.29%371M-13.64%304M-10.39%319M
Current debt and capital lease obligation -32.12%2.23B-32.12%2.23B-77.87%1.24B16.31%3.71B117.55%6.36B-25.43%3.28B-25.43%3.28B144.32%5.62B-37.73%3.19B-62.00%2.92B
-Current debt -34.40%2.05B-34.40%2.05B-80.28%1.08B16.92%3.53B124.93%6.19B-26.85%3.12B-26.85%3.12B156.43%5.47B-39.03%3.02B-63.41%2.75B
-Current capital lease obligation 11.73%181M11.73%181M10.00%165M5.36%177M-1.17%169M19.12%162M19.12%162M-10.18%150M0.60%168M0.00%171M
Other current liabilities 12.25%12.91B12.25%12.91B20.27%13.43B14.86%11.6B24.96%12.06B8.82%11.5B8.82%11.5B8.61%11.17B6.68%10.1B6.26%9.65B
Current liabilities 6.79%23.77B6.79%23.77B-3.51%22.64B15.46%23.27B35.30%25.82B1.70%22.26B1.70%22.26B23.94%23.46B-3.66%20.15B-16.37%19.09B
Non current liabilities
Long term debt and capital lease obligation 28.26%48.97B28.26%48.97B49.05%50.16B39.72%50.3B40.06%51.05B5.14%38.18B5.14%38.18B-11.00%33.65B-5.07%36B-4.84%36.45B
-Long term debt 29.87%47.6B29.87%47.6B51.46%48.67B40.98%48.86B41.08%49.49B4.56%36.65B4.56%36.65B-13.06%32.14B-6.61%34.66B-6.33%35.08B
-Long term capital lease obligation -10.46%1.37B-10.46%1.37B-1.98%1.48B7.15%1.44B14.09%1.56B21.33%1.53B21.33%1.53B79.05%1.51B64.66%1.34B60.80%1.37B
Non current deferred liabilities -0.94%1.06B-0.94%1.06B5.00%1.15B-18.09%1.19B-47.33%1.19B-61.94%1.07B-61.94%1.07B-68.73%1.1B-60.65%1.45B-50.12%2.26B
Employee benefits -16.67%400M-16.67%400M15.80%447M17.09%466M19.55%477M19.40%480M19.40%480M-30.20%386M-32.43%398M-36.16%399M
Other non current liabilities 31.82%522M31.82%522M36.50%531M96.59%576M98.63%582M30.69%396M30.69%396M51.95%389M40.19%293M36.28%293M
Total non current liabilities 20.80%52.44B20.80%52.44B38.96%53.83B31.48%54.31B30.83%56.66B-0.91%43.41B-0.91%43.41B-16.75%38.74B-11.70%41.31B-10.83%43.31B
Total liabilities 16.05%76.22B16.05%76.22B22.94%76.47B26.23%77.58B32.19%82.48B-0.04%65.67B-0.04%65.67B-4.98%62.2B-9.21%61.46B-12.60%62.4B
Shareholders'equity
Share capital 0.00%292M0.00%292M0.00%292M0.00%292M0.00%292M0.00%292M0.00%292M0.00%292M0.00%292M0.00%292M
-common stock 0.00%292M0.00%292M0.00%292M0.00%292M0.00%292M0.00%292M0.00%292M0.00%292M0.00%292M0.00%292M
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -48.16%14.91B-48.16%14.91B-42.95%16.1B-41.33%16.1B-41.13%15.64B12.79%28.77B12.79%28.77B14.36%28.22B13.35%27.45B10.94%26.57B
Paid-in capital 0.74%46.02B0.74%46.02B2.33%45.9B1.03%45.77B1.14%45.66B1.15%45.68B1.15%45.68B-0.24%44.85B2.08%45.3B3.16%45.14B
Less: Treasury stock -0.25%43.66B-0.25%43.66B1.39%43.68B10.11%43.69B12.60%43.7B13.33%43.77B13.33%43.77B18.30%43.08B12.43%39.68B10.29%38.81B
Gains losses not affecting retained earnings 19.92%-1.24B19.92%-1.24B-14.15%-1.47B-4.97%-1.46B-2.34%-1.4B-20.69%-1.55B-20.69%-1.55B-52.91%-1.29B-39.82%-1.39B-11.31%-1.37B
Total stockholders'equity -44.50%16.34B-44.50%16.34B-40.89%17.14B-46.78%17.02B-48.18%16.49B-5.25%29.43B-5.25%29.43B-11.24%29B-1.92%31.97B0.77%31.82B
Noncontrolling interests -3.64%53M-3.64%53M-9.38%58M-5.26%54M-6.45%58M-3.51%55M-3.51%55M1.59%64M-6.56%57M-4.62%62M
Total equity -44.42%16.39B-44.42%16.39B-40.82%17.2B-46.71%17.07B-48.10%16.55B-5.25%29.49B-5.25%29.49B-11.22%29.06B-1.93%32.03B0.76%31.89B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Alibaba
BABA
+4.34%
Micron Technology
MU
+4.04%
NVIDIA
NVDA
+2.63%
Cisco
CSCO
+1.61%
Netflix
NFLX
+1.43%

Unlock the Full List

Investment Theme Cancer Research
Cancer Research
Intraday-1.84%